Value of Cancer Ratio plus and Cancer Ratio Formulation in Distinguishing Malignant Pleural Effusion from Tuberculosis and Parapneumonic Effusion

BACKGROUND: The aim of our study is to determine the clinical availability accessibility of cancer ratio and cancer ratio plus formulations, previously validated and reported to have clinical value in distinguishing malignant pleural effusion from tuberculosis pleurisy and parapneumonic effusion. MA...

Descripción completa

Detalles Bibliográficos
Autores principales: Gayaf, Mine, Anar, Ceyda, Canbaz, Mustafa, Tatar, Dursun, Güldaval, Filiz
Formato: Online Artículo Texto
Lenguaje:English
Publicado: National Research Institute of Tuberculosis and Lung Disease 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8978044/
https://www.ncbi.nlm.nih.gov/pubmed/35382086

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8978044/
https://www.ncbi.nlm.nih.gov/pubmed/35382086

Ejemplares similares